Sysmex Group’s Largest Manufacturing Base Completed in India
Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announces today the completion of construction of a new manufacturing base in India, which is the Group’s first factory capable of producing both reagents and instruments.
The new manufacturing base has the largest total floor area of all the Sysmex Group’s manufacturing bases outside Japan. It has the capacity to significantly expand the range of reagents produced and to produce instrument products in response to the Make in India policy of the Government of India. This will strengthen our supply capacity for robust testing demand and aim for accelerated business expansion and sustained growth in India.
In India, against the backdrop of rapid economic and population growth, investments in medical infrastructure are being actively implemented through both government initiatives and private capital. High demand and sustained market growth in the areas of testing and diagnosis are expected to continue in the future.
In addition to the reinforced manufacturing capacity in anticipation of increased demand for testing over the medium to long term, the new manufacturing base has the scalability to allow for future expansion of production items for both reagents and instruments. The new manufacturing base will also serve as a warehouse and logistics hub to optimize the supply chain in India.
For instrument production, in addition to relocating and establishing production processes and systems equivalent to those in factories in Japan, various measures are planned to be implemented to achieve and maintain Sysmex’s high quality standards in India, such as introducing a training system for local employees using IT. In addition, Sysmex will gradually expand domestic procurement of raw materials in India in response to the Make in India policy.
Going forward, preparations will be made for full-scale operation. The plan is to start shipments of both reagents and instruments by the end of fiscal year 2024.
Based on its strong commitment to the progress of healthcare in India, in addition to the new manufacturing base, Sysmex is making aggressive investments, including the expansion of sales and service bases, and the development and launch of products for the Indian market, in order to enhance the effectiveness of the emerging market strategies set out in the mid-term management plan and achieve the sustainable growth of the Group.
Overview of new manufacturing base in India
| Location: |
Sanand II Industrial Estate, Gujarat, India
|
||
| Site area: | 18,100㎡ | ||
| Floor space: |
10,600㎡
|
||
| Investment: | Approx. 3 billion JPY | ||
| Products manufactured: | Reagents, instruments (some models of hematology analyzers) | ||
Developments in Sysmex’s business in the Indian market
Sysmex’s business in India began in 1998 with the establishment of a local joint venture (presently Sysmex India Pvt. Ltd.) It became a wholly-owned subsidiary in 2008, and its direct sales and services and support have seen steady growth, beginning with urinalysis in 2012 and progressing to hemostasis and clinical chemistry testing in 2014, and hematology, its mainstay, in 2019. Thus, rapid expansion of the business, as well as the sales and service network, has been achieved. As for the product supply system in India, a reagent production factory was established in Baddi, Himachal Pradesh in 2007 to ensure a stable supply of reagent products to customers in India.
Reference
April 17, 2023 news release: “Sysmex to Establish New Manufacturing Base in India – Creating a Manufacturing Structure in India to Support Sustainable Growth -”
https://www.sysmex.co.jp/en/news/2023/230417.html